Mechanism of damnacanthal-induced [Ca2+](i) elevation in human dermal fibroblasts

Kazuya Aoki, Andrew Parent, John Zhang

Research output: Contribution to journalArticlepeer-review

Abstract

Damnacanthal is a potent and selective inhibitor of p56(lck) tyrosine kinase in a variety of tissues. We have found, however, using the Ca2+ microfluorimetry technique, that damnacanthal releases intracellular Ca2+ stores and promotes Ca2+ entry in human dermal fibroblasts. The effect of damnacanthal on the peak [Ca2+](i) values and the latent time to the peak was concentration-dependent. Damnacanthal releases Ca2+ from thapsigargin- sensitive Ca2+ stores, and the Ca2+ stores responding to damnacanthal were overlapped with those of bradykinin. Damnacanthal-induced Ca2+ entry was mediated by voltage-dependent and voltage-independent Ca2+ channels. This effect of damnacanthal on intracellular Ca2+ mobilization was also observed in cultured bovine coronary endothelial cells but not demonstrated in freshly isolated rat basilar smooth muscle cells. Our study suggests that damnacanthal increases intracellular Ca2+ by releasing Ca2+ from internal stores and promoting Ca2+ entry. The relationship between the actions of damnacanthal on tyrosine kinase and intracellular Ca2+ requires further investigation. (C) 2000 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)119-124
Number of pages6
JournalEuropean Journal of Pharmacology
Volume387
Issue number2
DOIs
StatePublished - Jan 10 2000
Externally publishedYes

ASJC Scopus Subject Areas

  • Pharmacology

Keywords

  • Ca, intracellular
  • Damnacanthal
  • Dermal fibroblast
  • Tyrosine kinase
  • Humans
  • Cells, Cultured
  • Rats
  • Thapsigargin/pharmacology
  • Anthraquinones/pharmacology
  • Enzyme Inhibitors/pharmacology
  • Calcium/metabolism
  • Dose-Response Relationship, Drug
  • Animals
  • Cattle
  • Fibroblasts/metabolism
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/antagonists & inhibitors
  • Skin/cytology
  • Bradykinin/pharmacology

Cite this